Compare ABCL & CRTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABCL | CRTO |
|---|---|---|
| Founded | 2012 | 2005 |
| Country | Canada | France |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 980.6M |
| IPO Year | 2020 | 2013 |
| Metric | ABCL | CRTO |
|---|---|---|
| Price | $3.51 | $18.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | $7.75 | ★ $35.90 |
| AVG Volume (30 Days) | ★ 2.3M | 258.4K |
| Earning Date | 05-11-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 10.91 | ★ 38.95 |
| EPS | N/A | ★ 2.64 |
| Revenue | $75,128,000.00 | ★ $2,296,692,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $25.44 | $5.54 |
| P/E Ratio | ★ N/A | $7.01 |
| Revenue Growth | ★ 160.56 | 27.65 |
| 52 Week Low | $1.89 | $16.15 |
| 52 Week High | $6.52 | $35.10 |
| Indicator | ABCL | CRTO |
|---|---|---|
| Relative Strength Index (RSI) | 53.38 | 55.34 |
| Support Level | $3.37 | $17.83 |
| Resistance Level | $3.57 | $19.79 |
| Average True Range (ATR) | 0.15 | 0.72 |
| MACD | 0.01 | 0.12 |
| Stochastic Oscillator | 65.63 | 79.94 |
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.
Criteo SA is an ad-tech company in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.